DARAXON / SHANGHAI
API expertise. Formulation perspective.
Three core APIs and complementary Daraxonrasib SDD materials for pharmaceutical development and registration teams.
Company identity
Daraxon
SHANGHAI DA'AN XIN BIOMEDICAL CO LTD is the company name in the FDA DMF list. SHANGHAI DARAXON BIOMEDICAL CO LTD is an alternative English rendering of the same company. Daraxon is the brand used on this website.
Our portfolio includes Daraxonrasib API, Zoldonrasib API and Vopimetostat API, plus Daraxonrasib SDD spray-dried powder and an excipient-containing SDD premix for direct compression.
First-supplier positioning
The world’s first supplier of three APIs.
Company statement
Daraxon is the world’s first supplier of Daraxonrasib, Zoldonrasib and Vopimetostat APIs, and of Daraxonrasib SDD spray-dried powder and excipient-containing SDD premix for direct compression.
Global-first positioning is a company statement. FDA DMF records identify files and holders; they do not certify global supplier rankings.
Public filing records
Three APIs. Three Type II DMFs.
In the FDA 2026 Q2 public list, each of these three product names appears in a single record, all held under our FDA-registered name.
| API | FDA DMF | Type / status | Submitted |
|---|---|---|---|
| DARAXONRASIB | 43871 | II / A (Active) | 2026-03-17 |
| ZOLDONRASIB | 44304 | II / A (Active) | 2026-06-08 |
| VOPIMETOSTAT | 44318 | II / A (Active) | 2026-06-11 |
Work with Daraxon
Tell us what your program needs.
Start with material selection, specifications and the documentation for your program.